
MinnPost thanks these major sponsors:
Sponsor of
Second Opinion
Sponsor of
Community Sketchbook
Our major advertisers
Our in-kind partners

MinnPost thanks these generous donors:
INDIVIDUALS AND FOUNDATI0NS
Blandin Foundation
Otto Bremer Foundation
Bush Foundation
Sage & John Cowles
David & Vicki Cox
Toby & Mae Dayton
Jack & Claire Dempsey
Ethics and Excellence in Journalism Foundation
Sam & Stacey Heins
John S. and James L. Knight Foundation
Joel & Laurie Kramer
Lee Lynch & Terry Saario
Martin & Brown Foundation
The McKnight Foundation
The Minneapolis Foundation
The Saint Paul Foundation
Rebecca & Mark Shavlik
(See all donors here.)
By Dan Haugen | Published Tue, Feb 17 2009 9:41 am
Medtronic is selling fewer pacemakers and defibrillators but more drug-coated stents and neuromodulation products.
The Fridley-based medical device company reported today that revenue for the three months ending Jan. 23 rose 3 percent from a year ago to $3.5 billion.
“Despite global macroeconomic uncertainties and an unfavorable impact from foreign currency on our business units this quarter, Medtronic continues to deliver growth in a challenging environment,” CEO Bill Hawkins said in the company's statement.
Sales revenue from the company's cardiac rhythm disease management unit, which includes pacemakers and defibrillators, decreased 4 percent from last year.
CardioVascular, which includes the company's coronary stent products, increased 10 percent. Neuromodulation, a unit that uses pacemaker-like devices to treat pain and other conditions, saw revenue grow 11 percent, the company reported.
Like what you just read? Support high-quality journalism in Minnesota by becoming a member of MinnPost.
0 Comments:
Forgot Password? | Register to Comment
MinnPost does not permit the use of foul language, personal attacks or the use of language that may be libelous or interpreted as inciting hate or sexual harassment. User comments are reviewed by moderators to ensure that comments meet these standards and adhere to MinnPost's terms of use and privacy policy.
We intend for this area to be used by our readers as a place for civil, thought-provoking and high-quality public discussion. In order to achieve this, MinnPost requires that all commenters register and post comments with their actual names and place of residence. Register here to comment.